ReviewCureus2024

Effectiveness of Pfizer Vaccine BNT162b2 Against SARS-CoV-2 in Americans 16 and Older: A Systematic Review.

Justin Wilburn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.